Australia markets open in 3 hours 20 minutes

Petros Pharmaceuticals, Inc. (PTPI)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.5190-0.0952 (-15.50%)
At close: 04:00PM EDT
0.5293 +0.01 (+1.98%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.45M
Enterprise value 2.29M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.37
Price/book (mrq)0.44
Enterprise value/revenue 0.46
Enterprise value/EBITDA -0.10

Trading information

Stock price history

Beta (5Y monthly) 2.45
52-week change 3-75.14%
S&P500 52-week change 323.49%
52-week high 34.7400
52-week low 30.4667
50-day moving average 30.8150
200-day moving average 31.3917

Share statistics

Avg vol (3-month) 3499.23k
Avg vol (10-day) 3125.54k
Shares outstanding 57M
Implied shares outstanding 67M
Float 86.33M
% held by insiders 111.59%
% held by institutions 10.92%
Shares short (15 May 2024) 484.74k
Short ratio (15 May 2024) 40.28
Short % of float (15 May 2024) 41.50%
Short % of shares outstanding (15 May 2024) 41.21%
Shares short (prior month 15 Apr 2024) 469.84k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 301 Dec 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -190.50%
Operating margin (ttm)-282.85%

Management effectiveness

Return on assets (ttm)-27.47%
Return on equity (ttm)-68.40%

Income statement

Revenue (ttm)4.69M
Revenue per share (ttm)1.65
Quarterly revenue growth (yoy)-44.80%
Gross profit (ttm)N/A
EBITDA -10.21M
Net income avi to common (ttm)-20.46M
Diluted EPS (ttm)-7.6300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.08M
Total cash per share (mrq)1.58
Total debt (mrq)8.14M
Total debt/equity (mrq)76.09%
Current ratio (mrq)1.60
Book value per share (mrq)1.42

Cash flow statement

Operating cash flow (ttm)-8.01M
Levered free cash flow (ttm)-2M